Causeway Therapeutics
PrivateLast Round
VC Round
Feb 27, 2023
Total Funding Raised
$6.36M
Company Overview
Causeway Therapeutics operates in Healthcare & Life Sciences and is based in Glasgow. Its latest recorded funding round was a VC Round in February 2023.
Causeway Therapeutics is a clinical-stage biotechnology company developing novel microRNA-based medicines to treat tendon disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Causeway Therapeutics Comparables
Compare Causeway Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| miRecule, Inc. | 63% | |
| Viridian Therapeutics | 59% | |
| Zimmer Biomet | 59% |
For institutional investors. Book with your work email.
Causeway Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Feb 27, 2023 | ||||
| Grant | May 1, 2020 | ||||
| Grant | Jun 1, 2019 | ||||
| Seed | Sep 27, 2018 | ||||
| Grant | May 30, 2018 | ||||
Seed | Aug 3, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Causeway Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovate UK | Grant |
| Mediqventures | VC Round, Seed |
| Scottish National Investment Bank | Seed, VC Round |
| Glasgow University Holdings Ltd | VC Round |
| Scottish Investment Bank (Scottish Enterprise) | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 14, 2026
Monthly visitors grew 424% MoM, reaching 1.2K.
For institutional investors. Book with your work email.
Causeway Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Causeway Therapeutics's valuation, stock price, and market status.
Is Causeway Therapeutics a public or private company?
Causeway Therapeutics is a private company.
What is the current stock price of Causeway Therapeutics?
Causeway Therapeutics is a private company, so its shares have no public market price. Caplight tracks Causeway Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Causeway Therapeutics worth (valuation)?
Valuation information for Causeway Therapeutics is not publicly available.
Can I buy Causeway Therapeutics stock?
Causeway Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Causeway Therapeutics's last funding round?
Causeway Therapeutics's most recent funding round was VC Round on February 27, 2023.
Who are the main investors in Causeway Therapeutics?
Key investors in Causeway Therapeutics include Innovate UK, Mediqventures, Scottish National Investment Bank, Glasgow University Holdings Ltd, Scottish Investment Bank (Scottish Enterprise).
Will Causeway Therapeutics IPO soon?
No public IPO plans have been announced for Causeway Therapeutics.
How can I track Causeway Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Causeway Therapeutics's shares on secondary markets.